Filed: 8/14/2026ACC: 0001892688-26-000119
📋 What this filing means
DIADEMA PARTNERS LP filed this quarterly 13F‑HR report disclosing 116 equity positions with a total reported market value of $791.35M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
116
Positions
$791.35M
Total AUM (reported)
28.86M
Total Shares
Allocation by class
COM$494.70M62.5%
SPONSORED ADS$113.03M14.3%
COM NEW$62.39M7.9%
SHS$26.59M3.4%
SPONSORED ADR$23.51M3.0%
NOTE 1.750% 3/0$18.62M2.4%
COM CL A$13.65M1.7%
Portfolio Concentration
Top 3$233.92M29.6%
4–10$164.69M20.8%
11–25$200.18M25.3%
Rest$192.55M24.3%
Top 3 weight
29.6%
Top 10 weight
50.4%
Voting Authority Distribution
Total shares with voting rights: 28.86M
Sole
Full voting authority
28.86M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole116
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings116
Rows:
ABIVAX SA
SOLEShares765.24K
TypeSH
Market value$101.77M
12.86%
Sole
765.24K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares2.01M
TypeSH
Market value$78.53M
9.92%
Sole
2.01M
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares930.60K
TypeSH
Market value$53.62M
6.78%
Sole
930.60K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares52.99K
TypeSH
Market value$28.71M
3.63%
Sole
52.99K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares139.22K
TypeSH
Market value$26.07M
3.29%
Sole
139.22K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares534.40K
TypeSH
Market value$24.61M
3.11%
Sole
534.40K
Shared
0.00
None
0.00
NOVARTIS AG
SOLEShares150K
TypeSH
Market value$23.51M
2.97%
Sole
150K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares561.72K
TypeSH
Market value$21.88M
2.77%
Sole
561.72K
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares863.70K
TypeSH
Market value$20.80M
2.63%
Sole
863.70K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares493.66K
TypeSH
Market value$19.10M
2.41%
Sole
493.66K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares250K
TypePRN
Market value$18.62M
2.35%
Sole
250K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares206.30K
TypeSH
Market value$17.94M
2.27%
Sole
206.30K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares312.85K
TypeSH
Market value$17.90M
2.26%
Sole
312.85K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares149.70K
TypeSH
Market value$17.17M
2.17%
Sole
149.70K
Shared
0.00
None
0.00
SUMMIT THERAPEUTICS INC
SOLEShares1.12M
TypeSH
Market value$16.32M
2.06%
Sole
1.12M
Shared
0.00
None
0.00
HIMS & HERS HEALTH INC
SOLEShares393.70K
TypeSH
Market value$13.65M
1.72%
Sole
393.70K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares1.20M
TypeSH
Market value$13.27M
1.68%
Sole
1.20M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares60K
TypeSH
Market value$12.96M
1.64%
Sole
60K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares10K
TypeSH
Market value$11.99M
1.52%
Sole
10K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares105.40K
TypeSH
Market value$11.95M
1.51%
Sole
105.40K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares272.21K
TypeSH
Market value$11.06M
1.40%
Sole
272.21K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares347.81K
TypeSH
Market value$10.72M
1.36%
Sole
347.81K
Shared
0.00
None
0.00
BIONTECH SE
SOLEShares100K
TypeSH
Market value$9.30M
1.18%
Sole
100K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares935.06K
TypeSH
Market value$8.77M
1.11%
Sole
935.06K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares147.07K
TypeSH
Market value$8.55M
1.08%
Sole
147.07K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 765.24K | SH | $101.77M 12.86% | 765.24K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 2.01M | SH | $78.53M 9.92% | 2.01M | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 930.60K | SH | $53.62M 6.78% | 930.60K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 52.99K | SH | $28.71M 3.63% | 52.99K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 139.22K | SH | $26.07M 3.29% | 139.22K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 534.40K | SH | $24.61M 3.11% | 534.40K | 0.00 | 0.00 |
NOVARTIS AGSOLE | SPONSORED ADR | 150K | SH | $23.51M 2.97% | 150K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 561.72K | SH | $21.88M 2.77% | 561.72K | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 863.70K | SH | $20.80M 2.63% | 863.70K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 493.66K | SH | $19.10M 2.41% | 493.66K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 1.750% 3/0 | 250K | PRN | $18.62M 2.35% | 250K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 206.30K | SH | $17.94M 2.27% | 206.30K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 312.85K | SH | $17.90M 2.26% | 312.85K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 149.70K | SH | $17.17M 2.17% | 149.70K | 0.00 | 0.00 |
SUMMIT THERAPEUTICS INCSOLE | COM | 1.12M | SH | $16.32M 2.06% | 1.12M | 0.00 | 0.00 |
HIMS & HERS HEALTH INCSOLE | COM CL A | 393.70K | SH | $13.65M 1.72% | 393.70K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 1.20M | SH | $13.27M 1.68% | 1.20M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 60K | SH | $12.96M 1.64% | 60K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 10K | SH | $11.99M 1.52% | 10K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 105.40K | SH | $11.95M 1.51% | 105.40K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 272.21K | SH | $11.06M 1.40% | 272.21K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 347.81K | SH | $10.72M 1.36% | 347.81K | 0.00 | 0.00 |
BIONTECH SESOLE | SPONSORED ADS | 100K | SH | $9.30M 1.18% | 100K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 935.06K | SH | $8.77M 1.11% | 935.06K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 147.07K | SH | $8.55M 1.08% | 147.07K | 0.00 | 0.00 |
Page 1 of 5
…